নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

merck sharp & dohme b.v. - montelukastnatrium - granulat i dosepose - 4 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

n.v. organon - kloosterstraat - montelukastnatrium - tyggetablett - 4 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm as - montelukastnatrium - tyggetablett - 4 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

mundipharma as - flutikasonpropionat / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 250 mikrog / 10 mikrog

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

mundipharma as - flutikasonpropionat / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 50 mikrog / 5 mikrog

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

mundipharma as - flutikasonpropionat / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 125 mikrog / 5 mikrog

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

mundipharma as - flutikasonpropionat / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 50 mikrog / 5 mikrog

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

mundipharma as - flutikasonpropionat / formoterolfumaratdihydrat - inhalasjonsaerosol, suspensjon - 125 mikrog / 5 mikrog

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

pharmaxis europe limited - mannitol - inhalasjonspulver, hard kapsel - 20 mg / 40 mg / 10 mg / 0 mg / 5 mg

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibakterielle midler for systemisk bruk, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler. riktig bruk av antibakterielle midler.